CSL is a brand that is committed to sustainability and making a positive impact on the world. They have set ambitious emissions reduction targets as part of their broader strategy to decarbonize global operations. The brand consists of four main sections: CSL Behring, CSL Plasma, CSL Seqirus, and CSL Vifor.

CSL Behring offers a wide range of quality plasma-derived and recombinant therapies for rare and serious diseases. CSL Seqirus is one of the largest influenza vaccine providers worldwide. CSL Vifor focuses on managing access programs.

Additionally, CSL is actively involved in research and development, with a focus on plasma protein technology, recombinant technology, cell and gene therapy, and vaccines technology. The brand is also committed to sustainability, with initiatives in energy and emissions reduction, waste management, and social responsibility. CSL's dedication to innovation, patient care, and sustainability makes it a trusted leader in the biotech industry